Ambeed.cn

首页 / / / Pim / SMI-4a

SMI-4a 99%+

货号:A107880 同义名: TCS-PIM-1-4a Ambeed 开学季,买赠积分,赢豪礼

SMI-4a is a potent inhibitor of Pim1 with IC50 of 17 nM, modestly potent to Pim-2, does not significantly inhibit any other serine/threonine- or tyrosine-kinases.

SMI-4a 化学结构 CAS号:438190-29-5
SMI-4a 化学结构
CAS号:438190-29-5
SMI-4a 3D分子结构
CAS号:438190-29-5
SMI-4a 化学结构 CAS号:438190-29-5
SMI-4a 3D分子结构 CAS号:438190-29-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

SMI-4a 纯度/质量文件 产品仅供科研

货号:A107880 标准纯度: 99%+
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell,2024. Ambeed. [ A125712 ]
Cancer Discov., 2024. Ambeed. [ A285925 ]
JMC, 2024, 67(17): 14974-14985. Ambeed. [ A288696 ]
JMC, 2024, 67(17): 15061-15079. Ambeed. [ A524399 , A633512 , A144280 , A174613 ]
EJNMMI Radiopharm. Chem., 2024, 9, 61. Ambeed. [ A1257961 , A622068 ]
更多 >
产品名称 Pim1 Pim2 Pim3 其他靶点 纯度
SMI-4a ++

Pim1, IC50: 17 nM

99%+
SGI-1776 free base ++

Pim1, IC50: 7 nM

+

Pim2, IC50: 363 nM

+

Pim3, IC50: 69 nM

FLT3 99+%
AZD-1208 +++

Pim1, IC50: 0.4 nM

+++

Pim2, IC50: 5 nM

+++

Pim3, IC50: 1.9 nM

98%
CX-6258 HCl +++

Pim1, IC50: 5 nM

+

Pim2, IC50: 25 nM

++

Pim3, IC50: 16 nM

98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

SMI-4a 生物活性

靶点
  • Pim1

    Pim1, IC50:17 nM

描述 Pim (provirus integration site for Moloney murine leukemia virus) family proteins are highly conserved serine/threonine kinases implicated in transcription, translation, cell cycle, survival, and drug resistance through the numerous targets. SMI-4a is a potent inhibitor of Pim1 with IC50 of 17 nM (measured by kinase activity assay), as well as shows modest potency to Pim-2. As BAD is a novel substrate of Pim-1, SMI-4a < 5 μM caused dose-dependent reduction of p-BAD in prostate and hematopoietic cells tested. Treatment with 5 μM SMI-4a for 72 h showed various degree of growth inhibition (10-40%) of PC3, DU145, LNCaP, U937, K562 and MV4;11 cells cultured in media containing 10% FBS. Because SMI-4a showed to be serum-bound, it was found that DU145 cells became considerably more sensitive under serum-free conditions. For many substrates of Pim-1 play a role in cell cycle progression, as prediction, treatment with 5 μM SMI-4a for 72 h caused a significant G1 cell cycle arrest of DU145 cells growing in 2% serum and MV4;11 cells plated in 10% serum, as well as a considerable amount of apoptosis (sub-G1 29.2%) of 22Rv1 cells cultured under serum starvation condition. The translocation of p27Kip1 to the nucleus and reduced Cdk2 activity (shown by decreased p-H1) can also observed in K562 cells cultured in RPMI containing 10% FCS after treatment with SMI-4a. SMI-4a can synergize with rapamycin to cause significant growth inhibition, as well as decreased phosphorylation level of 4E-BP1 of MV4;11 and FDCP1 (IL-3 dependent) cells[1]. Combination treatment of ABT-737 (50 mg/kg; i.p., QD) and SMI-4a (60 mg/kg, oral gavage, BID) for 16 days significantly reduce the tumor growth of LNCaP xenograft model[2].
作用机制 SMI-4a can compete with respect to ATP, suggesting that it may bind within the ATP-binding pocket of the kinase.[1]

SMI-4a 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
DLD-1 cell Function assay 96 h Inhibition of growth of DLD-1 cell line after 96 hours of exposure time with the compound dissolved in DMSO, IC50=17.8 μM 15993594
HCT116 cell Function assay 72 h Inhibition of growth of HCT116 cell line after 72 hours of exposure time with the compound dissolved in DMSO, IC50=48.8 μM 15993594
HEK293T cells 0.5 μM Function assay 1 h Inhibition of human recombinant Flag-Pim1 autophosphorylation expressed in HEK293T cells labeled with [32PO4] at 0.5 uM after 1hr by Western blotting 19072652
HT-29 cell Function assay Inhibition of growth of HT-29 cell line after 72+72 hours of exposure time with the compound dissolved in DMSO, IC50=31.4 μM 15993594

SMI-4a 动物研究

Dose Mice: 60 mg/kg[4] (p.o.), 5 mg/kg - 40 mg/kg[5], 15 mg/kg[6] (intratumorally)
Administration p.o., intratumorally
Pharmacokinetics
Animal Mice[4]
Dose 60 mg/kg
Administration p.o.
Cmax 200 μM
T1/2 6 h
Tmax 1 h

SMI-4a 参考文献

[1]Song JH, Kraft AS, et al. Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737. Cancer Res. 2012 Jan 1;72(1):294-303.

[2]Beharry Z, Zemskova M, et al. Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells. Mol Cancer Ther. 2009 Jun;8(6):1473-83.

[3]Lei C, Da-lun L, et al. Inhibition of autophagy enhances SMI-4a-induced growth inhibition and apoptosis of melanoma cells. TJPR. 2018 Mar; 17 (3): 401-407.

[4]Lin YW, Beharry ZM, et al. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood. 2010 Jan 28;115(4):824-33.

[5]Jiang W, Chen Y, et al. Pim-1 inhibitor SMI-4a suppresses tumor growth in non-small cell lung cancer via PI3K/AKT/mTOR pathway. Onco Targets Ther. 2019 Apr 23;12:3043-3050.

[6]Lv DL, Chen L, et al. Ginsenoside G-Rh2 synergizes with SMI-4a in anti-melanoma activity through autophagic cell death. Chin Med. 2018 Feb 21;13:11.

SMI-4a 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.66mL

0.73mL

0.37mL

18.30mL

3.66mL

1.83mL

36.60mL

7.32mL

3.66mL

SMI-4a 技术信息

CAS号438190-29-5
分子式C11H6F3NO2S
分子量 273.231
别名 TCS-PIM-1-4a
运输蓝冰
存储条件

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 105 mg/mL(384.29 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方

IP 2% DMSO+2% Tween80+40% PEG300+water 5 mg/mL clear

PO 0.5% CMC-Na 43 mg/mL suspension

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。